These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2080069)
41. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. Slots J; Rosling BG J Clin Periodontol; 1983 Sep; 10(5):465-86. PubMed ID: 6579058 [TBL] [Abstract][Full Text] [Related]
42. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use]. Jónsdóttir K; Kristinsson KG Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726 [TBL] [Abstract][Full Text] [Related]
43. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265 [TBL] [Abstract][Full Text] [Related]
44. Changes in the prevalence of subgingival enteric rods, staphylococci and yeasts after treatment with penicillin and erythromycin. Helovuo H; Hakkarainen K; Paunio K Oral Microbiol Immunol; 1993 Apr; 8(2):75-9. PubMed ID: 8355988 [TBL] [Abstract][Full Text] [Related]
45. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. Hansen GT; Blondeau JM J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436 [TBL] [Abstract][Full Text] [Related]
46. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients. Guimaraes MA; Noone P J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708 [TBL] [Abstract][Full Text] [Related]
47. Age and sex relationships of superinfecting microorganisms in periodontitis patients. Slots J; Feik D; Rams TE Oral Microbiol Immunol; 1990 Dec; 5(6):305-8. PubMed ID: 2098707 [TBL] [Abstract][Full Text] [Related]
48. Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Quesada MD; Giménez M; Molinos S; Fernández G; Sánchez MD; Rivelo R; Ramírez A; Banqué G; Ausina V Clin Microbiol Infect; 2010 Feb; 16(2):137-40. PubMed ID: 19778301 [TBL] [Abstract][Full Text] [Related]
49. Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Livermore DM; James D; Reacher M; Graham C; Nichols T; Stephens P; Johnson AP; George RC Emerg Infect Dis; 2002 May; 8(5):473-8. PubMed ID: 11996681 [TBL] [Abstract][Full Text] [Related]
50. In vitro experiments on catheter-related infections due to gram-negative rods. Penner J; Allerberger F; Dierich MP; Pfaller W; Hager J Chemotherapy; 1993; 39(5):336-54. PubMed ID: 8370325 [TBL] [Abstract][Full Text] [Related]
51. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital. Tantisiriwat W; Linasmita P J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484 [TBL] [Abstract][Full Text] [Related]
52. Clinical and microbiological features of refractory periodontitis subjects. Colombo AP; Haffajee AD; Dewhirst FE; Paster BJ; Smith CM; Cugini MA; Socransky SS J Clin Periodontol; 1998 Feb; 25(2):169-80. PubMed ID: 9495617 [TBL] [Abstract][Full Text] [Related]
53. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections]. Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174 [TBL] [Abstract][Full Text] [Related]
54. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009). Sader HS; Farrell DJ; Jones RN Diagn Microbiol Infect Dis; 2011 Feb; 69(2):223-7. PubMed ID: 21251571 [TBL] [Abstract][Full Text] [Related]
55. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa. Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715 [TBL] [Abstract][Full Text] [Related]
56. External otitis in divers: etiology and in vitro activity of ciprofloxacin and local agents. Dibb WL Chemioterapia; 1987 Jun; 6(2 Suppl):138-40. PubMed ID: 3509371 [No Abstract] [Full Text] [Related]
57. Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999. Fontana R; Lo Cascio G; Ligozzi M; Friscia O; Oldoni T; Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):854-63. PubMed ID: 11837636 [TBL] [Abstract][Full Text] [Related]